Related Experiment Video
Updated: May 30, 2026

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions
Published on: January 7, 2019
Mobilization of stem and progenitor cells in cardiovascular diseases
W Wojakowski1, U Landmesser, R Bachowski
1Third Division of Cardiology, Medical University of Silesia, Katowice, Poland. wojtek.wojakowski@gmail.com
Insights
Mobilized stem and progenitor cells (SPCs) from bone marrow aid vascular and heart repair after injury. Their function is impaired by cardiovascular risk factors but may predict outcomes in certain patients.
Area of Science:
- Cardiovascular Research
- Stem Cell Biology
- Regenerative Medicine
Background:
- Bone marrow-derived stem and progenitor cells (SPCs) are crucial for repairing vascular endothelium and heart muscle after acute coronary syndromes.
- Acute myocardial infarction triggers inflammation, mobilizing SPCs and increasing local chemoattractants, while neural and humoral signals promote their release from bone marrow.
- Various circulating SPC types exist, but their exact roles in myocardial and endothelial repair remain unclear.
Purpose of the Study:
- To review the mobilization of SPCs in acute ischemia and stable cardiovascular disease.
- To highlight the potential of SPCs as cardiovascular risk markers.
- To discuss factors influencing SPC mobilization and function.
Main Methods:
- Literature review of studies on stem and progenitor cell mobilization.
- Analysis of the role of SPCs in myocardial infarction and stroke.
- Examination of factors affecting SPC number and function, including cardiovascular risk factors, exercise, and statins.
Main Results:
- The number and function of circulating SPCs are reduced in patients with diabetes and other cardiovascular risk factors.
- Physical exercise and statin use can improve SPC function.
- Mobilization of SPCs in acute coronary syndromes and stable coronary artery disease may predict clinical outcomes.
Conclusions:
- SPCs play a role in cardiovascular repair, but their contribution requires further elucidation.
- Factors like coexisting diseases, age, and medications influence SPC mobilization and must be considered.
- Circulating SPCs hold potential as biomarkers for cardiovascular risk assessment.
Abstract:
Circulating bone marrow (BM)-derived stem and progenitor cells (SPCs) participate in turnover of vascular endothelium and myocardial repair after acute coronary syndromes. Acute myocardial infarction (MI) produces a generalized inflammatory reaction, including mobilization of SPCs, increased local production of chemoattractants in the ischemic myocardium, as well as neural and humoral signals activating the SPC egress from the BM. Several types of circulating BM cells were identified in the peripheral blood, including hematopoietic stem cells, endothelial progenitor cells, mesenchymal stromal cells, circulating angiogenic cells and pluripotent very small embryonic-like cells; however, the contribution of circulating cells to the myocardial and endothelial repair is still unknown. The number and function of these cells is impaired in patients with diabetes and other cardiovascular risk factors, but can be improved by physical exercise and use of statins. The mobilization of SPCs in acute coronary syndromes and stable coronary artery disease seems to predict the clinical outcomes in selected groups of patients. Interpretation of the findings has to incorporate other factors that modulate the process of mobilization, such as coexisting diseases, age and medications. This review discusses the mobilization of SPCs in acute ischemia (MI, stroke), as well as in stable cardiovascular disease, and highlights the possibility of using the SPC as a marker of cardiovascular risk.
Related Concept Videos
Multipotency of Hematopoietic Stem Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Regulation of Hematopoietic Stem Cells
Mesenchymal Stem Cells
Hematopoiesis
Stem Cell Culture

